• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Long-term follow up of patients with endomyocardial fibrosis: effects of surgery.心内膜心肌纤维化患者的长期随访:手术效果
Heart. 1998 Apr;79(4):362-7. doi: 10.1136/hrt.79.4.362.
2
[The course of endomyocardial fibrosis following surgical endocardial decortication].[外科心内膜剥脱术后心内膜心肌纤维化的病程]
Schweiz Med Wochenschr. 1984 Nov 10;114(45):1595-8.
3
Usefulness of echocardiography and doppler echocardiography in endomyocardial fibrosis.超声心动图及多普勒超声心动图在心肌内膜纤维化中的应用价值
J Am Soc Echocardiogr. 2000 May;13(5):385-92. doi: 10.1016/s0894-7317(00)70008-3.
4
[Clinical aspects and course of endomyocardial fibrosis].[心内膜心肌纤维化的临床特征与病程]
Schweiz Med Wochenschr. 1977 Jan 15;107(2):49-57.
5
Surgical treatment of endomyocardial fibrosis: a new approach.心内膜心肌纤维化的外科治疗:一种新方法。
J Am Coll Cardiol. 1990 Nov;16(5):1246-51. doi: 10.1016/0735-1097(90)90561-3.
6
Left ventricle endomyocardial fibrosis: a case report.左心室心肌纤维化:病例报告。
J Med Case Rep. 2023 Aug 12;17(1):361. doi: 10.1186/s13256-023-04056-z.
7
Surgical treatment of endomyocardial fibrosis.心内膜心肌纤维化的外科治疗
J Thorac Cardiovasc Surg. 1983 May;85(5):738-45.
8
The surgical treatment of endomyocardial fibrosis: results in 55 patients.心内膜心肌纤维化的外科治疗:55例患者的治疗结果
Circulation. 1985 Sep;72(3 Pt 2):II274-9.
9
[Surgery of endomyocardial fibrosis. Apropos of 32 cases].[心内膜心肌纤维化的外科治疗。附32例报告]
Arch Mal Coeur Vaiss. 1990 Apr;83(4):481-6.
10
Endomyocardial fibrosis: report of 6 patients and review of the surgical literature.心内膜心肌纤维化:6例报告及外科文献综述
Ann Thorac Surg. 1980 Mar;29(3):243-8. doi: 10.1016/s0003-4975(10)61875-9.

引用本文的文献

1
Endomyocardial fibrosis: recent advances and future therapeutic targets.心内膜心肌纤维化:最新进展与未来治疗靶点
Nat Rev Cardiol. 2025 Feb 26. doi: 10.1038/s41569-025-01138-x.
2
Rheumatic Heart Disease and Endomyocardial Fibrosis: A Complex Novel Case of Heart Failure.风湿性心脏病与心内膜心肌纤维化:一例复杂的新型心力衰竭病例
JACC Case Rep. 2024 Nov 20;29(22):102723. doi: 10.1016/j.jaccas.2024.102723.
3
Endomyocardial fibrosis with ischaemic stroke.心肌心内膜纤维化伴脑梗死。
BMJ Case Rep. 2023 Dec 28;16(12):e258718. doi: 10.1136/bcr-2023-258718.
4
A review on cardiac manifestation of parasitic infection.寄生虫感染的心脏表现综述。
Trop Parasitol. 2023 Jan-Jun;13(1):8-15. doi: 10.4103/tp.tp_45_21. Epub 2023 May 19.
5
French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes.法国嗜酸粒细胞增多症病因学检查和高嗜酸性粒细胞综合征管理指南。
Orphanet J Rare Dis. 2023 Apr 30;18(1):100. doi: 10.1186/s13023-023-02696-4.
6
Cardiovascular diseases in Africa in the twenty-first century: Gaps and priorities going forward.21世纪非洲的心血管疾病:未来的差距与优先事项
Front Cardiovasc Med. 2022 Nov 10;9:1008335. doi: 10.3389/fcvm.2022.1008335. eCollection 2022.
7
Trends in Annual Incidence Rates of Newly Diagnosed Endomyocardial Fibrosis Cases at the Uganda Heart Institute: A 14-Year Review.乌干达心脏研究所新诊断的心内膜心肌纤维化病例年发病率趋势:一项为期14年的回顾。
Front Cardiovasc Med. 2022 Apr 15;9:841346. doi: 10.3389/fcvm.2022.841346. eCollection 2022.
8
Immunomodulating Therapies in Acute Myocarditis and Recurrent/Acute Pericarditis.急性心肌炎和复发性/急性心包炎的免疫调节治疗
Front Med (Lausanne). 2022 Mar 7;9:838564. doi: 10.3389/fmed.2022.838564. eCollection 2022.
9
An unusual tropical endomyocardial fibrosis: a case report.一种不常见的热带心内膜心肌纤维化:病例报告。
Pan Afr Med J. 2022 Jan 4;41:8. doi: 10.11604/pamj.2022.41.8.32886. eCollection 2022.
10
Tropical Endomyocardial Fibrosis.热带心内膜心肌纤维化
JACC Case Rep. 2020 Apr 8;2(5):819-822. doi: 10.1016/j.jaccas.2020.02.020. eCollection 2020 May.

本文引用的文献

1
The idiopathic hypereosinophilic syndrome.特发性嗜酸性粒细胞增多综合征
Blood. 1994 May 15;83(10):2759-79.
2
Successful surgical treatment of two patients with eosinophilic endomyocardial disease.两名嗜酸性粒细胞性心内膜疾病患者的成功手术治疗
Br Heart J. 1981 Oct;46(4):438-45. doi: 10.1136/hrt.46.4.438.
3
Endomyocardial fibrosis: early and late results of surgery in 20 patients.心内膜心肌纤维化:20例患者手术的早期和晚期结果
J Thorac Cardiovasc Surg. 1982 Jan;83(1):52-64.
4
Surgical treatment of endomyocardial fibrosis.心内膜心肌纤维化的外科治疗
J Thorac Cardiovasc Surg. 1983 May;85(5):738-45.
5
[The course of endomyocardial fibrosis following surgical endocardial decortication].[外科心内膜剥脱术后心内膜心肌纤维化的病程]
Schweiz Med Wochenschr. 1984 Nov 10;114(45):1595-8.
6
Endomyocardial fibrosis: report on the hemodynamic data in 29 patients and review of the results of surgery.心内膜心肌纤维化:29例患者血流动力学数据报告及手术结果回顾
Am Heart J. 1983 Apr;105(4):659-66. doi: 10.1016/0002-8703(83)90491-x.
7
Necropsy study of endomyocardial fibrosis and rheumatic heart disease in Uganda 1950-1965.1950 - 1965年乌干达心内膜心肌纤维化和风湿性心脏病的尸检研究
Br Heart J. 1968 May;30(3):391-401. doi: 10.1136/hrt.30.3.391.
8
Endomyocardial biopsy in diagnosis of cardiomyopathies.心内膜心肌活检在心肌病诊断中的应用
Br Heart J. 1971 Nov;33(6):822-32. doi: 10.1136/hrt.33.6.822.
9
Postoperative evaluation of endomyocardial fibrosis.心内膜心肌纤维化的术后评估
Cardiology. 1986;73(2):73-84. doi: 10.1159/000173987.
10
The pathogenesis of endomyocardial fibrosis: the role of the eosinophil.心内膜心肌纤维化的发病机制:嗜酸性粒细胞的作用。
Springer Semin Immunopathol. 1989;11(4):471-7. doi: 10.1007/BF00201883.

心内膜心肌纤维化患者的长期随访:手术效果

Long-term follow up of patients with endomyocardial fibrosis: effects of surgery.

作者信息

Schneider U, Jenni R, Turina J, Turina M, Hess O M

机构信息

Division of Cardiology, University Hospital, Zurich, Switzerland.

出版信息

Heart. 1998 Apr;79(4):362-7. doi: 10.1136/hrt.79.4.362.

DOI:10.1136/hrt.79.4.362
PMID:9616343
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1728653/
Abstract

AIMS

To determine the long-term outcome of patients with endomyocardial fibrosis and to compare echocardiographic and haemodynamic data before and after ventricular endocardial resection.

PATIENTS

Seventeen patients (11 women and six men; mean age 35.5 years) diagnosed with endomyocardial fibrosis at the University Hospital in Zurich, Switzerland from 1971 to 1995. Twelve patients (70%) had partial obliteration of both ventricles and in five patients (30%) the fibrotic lesions were limited to the left ventricle.

METHODS

Fourteen of the 17 patients had surgical resection: fibrosis was resected from both ventricles in five patients and from the left ventricle only in nine patients. Ten patients had mitral valve replacement and two had tricuspid valve replacement. Left ventricle endocardial resection was done without reconstruction or replacement of the atrioventricular valve in three patients. Preoperative and postoperative echocardiographic data were available for 11 patients and haemodynamic data for six patients. Patients were followed up for 0.4-19 years (mean 8.6).

RESULTS

Preoperatively four patients were NYHA functional class IV and 10 were class III; postoperatively one patient was class III, seven class II, and six class I. Preoperatively, echocardiography showed obliteration of the left ventricular apex and inflow tract in all patients, which decreased or disappeared after surgery. Left ventricular end diastolic pressure decreased from 25 mm Hg before surgery to 14 mm Hg after successful resection of the fibrosis. Left ventricular and diastolic volume (normal 93 (17) ml/m2) increased from 65 ml/m2 to 97 ml/m2 (p < 0.05) after surgery. Ejection fraction was normal preoperatively (57%) and decreased slightly (52%) after surgery. One patient died five months after surgery from heart failure. Four surgically treated patients died during the follow up period: one each from systolic dysfunction, recurrence of endomyocardial fibrosis, pneumonia, and food poisoning. Overall survival was 65% at five years and 59% at 10 years; the survival rates of the operated patients was 72% and 68%, respectively. Only one of the medically treated patients survived longer than three years from diagnosis.

CONCLUSIONS

Endomyocardial fibrosis is a rare disease in European countries and is found mainly in women. The clinical picture is characterised by severe congestive heart failure but heart size is only moderately increased. Systolic performance is normal or only slightly depressed despite severe restriction to filling, atrioventricular valve regurgitation or both. Partial obliteration of the right and/or left ventricle may be detected by echocardiography. Endocardial resection with atrioventricular valve replacement is the treatment of choice with appreciable postoperative improvement and 10 year survival of approximately 70%.

摘要

目的

确定心内膜心肌纤维化患者的长期预后,并比较心室心内膜切除术前和术后的超声心动图及血流动力学数据。

患者

1971年至1995年在瑞士苏黎世大学医院诊断为心内膜心肌纤维化的17例患者(11例女性和6例男性;平均年龄35.5岁)。12例患者(70%)双侧心室部分闭塞,5例患者(30%)纤维化病变局限于左心室。

方法

17例患者中的14例行手术切除:5例患者双侧心室纤维化均被切除,9例患者仅左心室纤维化被切除。10例患者行二尖瓣置换术,2例患者行三尖瓣置换术。3例患者行左心室心内膜切除术时未重建或置换房室瓣。11例患者有术前和术后超声心动图数据,6例患者有血流动力学数据。对患者随访0.4至19年(平均8.6年)。

结果

术前4例患者为纽约心脏协会(NYHA)心功能IV级,10例为III级;术后1例患者为III级,7例为II级,6例为I级。术前,超声心动图显示所有患者左心室心尖和流入道闭塞,术后这种情况减少或消失。成功切除纤维化后,左心室舒张末期压力从术前的25 mmHg降至术后的14 mmHg。左心室舒张末期容积(正常为93(17)ml/m²)术后从65 ml/m²增加至97 ml/m²(p<0.05)。术前射血分数正常(57%),术后略有下降(52%)。1例患者术后5个月死于心力衰竭。4例接受手术治疗的患者在随访期间死亡:分别死于收缩功能障碍、心内膜心肌纤维化复发、肺炎和食物中毒。5年总生存率为65%,10年为59%;接受手术治疗患者的生存率分别为72%和68%。仅1例接受药物治疗的患者从诊断起存活超过3年。

结论

心内膜心肌纤维化在欧洲国家是一种罕见疾病,主要见于女性。临床表现为严重充血性心力衰竭,但心脏大小仅中度增加。尽管存在严重的充盈受限、房室瓣反流或两者皆有,收缩功能正常或仅轻度降低。超声心动图可检测到右心室和/或左心室部分闭塞。行房室瓣置换的心内膜切除术是首选治疗方法,术后有明显改善,10年生存率约为70%。